Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

JOURNAL ARTICLE published 29 March 2018 in New England Journal of Medicine

Research funded by Agenzia Italiana del Farmaco (FARM 5RWTWZ) | Efficacy and Mechanism Evaluation Programme (09/800/34) | Cancer Research United Kingdom (C1348/A15960) | National Institute for Health Research, Health Technology Assessment (14/140/84) | Programme Hospitalier de Recherche Clinique en Cancérologie (PHRC2009) | NIH Clinical Center (U10CA180821,U10CA180835,U10CA180882,U10CA180888)

Authors: Axel Grothey | Alberto F. Sobrero | Anthony F. Shields | Takayuki Yoshino | James Paul | Julien Taieb | John Souglakos | Qian Shi | Rachel Kerr | Roberto Labianca | Jeffrey A. Meyerhardt | Dewi Vernerey | Takeharu Yamanaka | Ioannis Boukovinas | Jeffrey P. Meyers | Lindsay A. Renfro | Donna Niedzwiecki | Toshiaki Watanabe | Valter Torri | Mark Saunders | Daniel J. Sargent | Thierry Andre | Timothy Iveson